20.12.2023 – 17:09Helmholtz Zentrum MünchenCells of the Future: A Key To Reprogramming Cell Identitiesmore
08.12.2023 – 11:13Helmholtz Zentrum MünchenNew Source of Stem Cells in Injury-Affected Brains of Patientsmore
06.12.2023 – 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmore
16.11.2023 – 10:27Fruit Vegetables EuropeTen benefits of a daily intake of citrus fruits during winter seasonmore
31.10.2023 – 10:00ARTTIC Innovation GmbH2PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHubPIONEER Videomore
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallOne documentmore
12.10.2023 – 14:00ARTTIC Innovation GmbHcanSERV Releases Open Call for Transnational Service ProvisioncanSERV CallOne documentmore
02.10.2023 – 17:06Helmholtz Zentrum MünchenDeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Timemore
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsOne documentmore
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyOne documentmore
09.08.2023 – 16:52Helmholtz Zentrum MünchenA New Ally in Fighting Brain Diseases: Our Very Own Skullmore
08.08.2023 – 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmore
07.08.2023 – 11:31Helmholtz Zentrum MünchenLife Science Factory to Open a New Location in Munich in 2024more
10.07.2023 – 17:08Helmholtz Zentrum MünchenWildDISCO: Visualizing Whole Bodies in Unprecedented Detailmore
05.07.2023 – 17:15Helmholtz Zentrum MünchenPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmore
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemore
28.06.2023 – 17:13Helmholtz Zentrum MünchenNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmore
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmore
15.06.2023 – 09:36Berlin CuresBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in Junemore
24.04.2023 – 10:01Sysmex Europe SE3Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca BiotechFind out more on MammaTyper here!more
23.03.2023 – 12:04hubergroup Deutschland GmbH5Press Release - hubergroup India expands its support for rural healthcareMore about hubergroupOne documentmore
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmore
01.03.2023 – 13:14ARTTIC Innovation GmbH2Free Access to Cancer Research Services - canSERV 1st Call for ProposalscanSERV websitemore
28.02.2023 – 19:00ARTTIC Innovation GmbHFree Access to Cancer Research Services - canSERV 1st Call for ProposalsAPPLY NOW!One documentmore
28.02.2023 – 07:30Fördergesellschaft IZB mbHInnovation and Start-up Center Biotechnology (IZB) welcomes InvitrisIn the IZB you can find over 50 biotech start-upsOne documentmore
27.02.2023 – 13:20Helmholtz Zentrum MünchenType 1 Diabetes Awareness Campaign - K1DS ARE HEROES - startedmore
08.02.2023 – 13:26BrainRepair UGBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully fundedmore
09.11.2022 – 10:39RHEACELL GmbH und Co. KGStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa researchmore